Close

Ratings by Stifel (Ben Burnett)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/22/2024 Gracell Biotechnologies Inc GRCL Downgrade Hold
(Buy)
10.25
(10.25)
0% Details
2/9/2024 Ideaya Biosciences IDYA Maintain Buy
(N/A)
 
 
  Details
12/12/2023 Disc Medicine IRON Maintain Buy
(N/A)
 
 
  Details
11/7/2023 Mirati Therapeutics MRTX Downgrade Hold
(Buy)
56.02
(58.70)
4.78% Details
10/19/2023 Gracell Biotechnologies Inc GRCL New Coverage Buy
(N/A)
2.61
(10.25)
292.72% Details
10/19/2023 Cabaletta Bio Inc. CABA New Coverage Buy
(N/A)
14.62
(22.39)
53.15% Details
9/21/2023 Revolution RVMD Maintain Buy
(N/A)
 
 
  Details
8/9/2023 Revolution RVMD Maintain Buy
(N/A)
 
 
  Details
8/9/2023 Mirati Therapeutics MRTX Maintain Buy
(N/A)
 
 
  Details
8/1/2023 Revolution RVMD Maintain Buy
(N/A)
 
 
  Details
6/23/2023 Disc Medicine IRON Maintain Buy
(N/A)
 
 
  Details
6/9/2023 Disc Medicine IRON Maintain Buy
(N/A)
 
 
  Details
5/15/2023 Disc Medicine IRON Maintain Buy
(N/A)
 
 
  Details
5/12/2023 Kinnate Biopharma KNTE Maintain Hold
(N/A)
 
 
  Details
4/24/2023 Ideaya Biosciences IDYA Upgrade Buy
(Hold)
14.93
(45.88)
207.3% Details
4/21/2023 Disc Medicine IRON New Coverage Buy
(N/A)
25.76
(65.00)
152.33% Details
4/18/2023 Kinnate Biopharma KNTE Maintain Hold
(N/A)
 
 
  Details
3/16/2023 Kinnate Biopharma KNTE Maintain Hold
(N/A)
 
 
  Details
3/14/2023 Arcellx Inc. ACLX New Coverage Buy
(N/A)
26.92
(62.01)
130.35% Details
3/7/2023 Ideaya Biosciences IDYA Maintain Hold
(N/A)
 
 
  Details
2/28/2023 Revolution RVMD Maintain Buy
(N/A)
 
 
  Details
12/9/2022 Mirati Therapeutics MRTX Maintain Buy
(N/A)
 
 
  Details
11/17/2022 Kinnate Biopharma KNTE Downgrade Hold
(Buy)
10.11
(2.51)
-75.17% Details
11/9/2022 Ideaya Biosciences IDYA Maintain Hold
(N/A)
 
 
  Details
8/15/2022 Ideaya Biosciences IDYA Downgrade Hold
(Buy)
15.65
(45.88)
193.16% Details
8/4/2022 Mirati Therapeutics MRTX Maintain Buy
(Buy)
 
 
  Details
7/13/2022 Revolution RVMD Maintain Buy
(Buy)
 
 
  Details
6/6/2022 Mirati Therapeutics MRTX Maintain Buy
(Buy)
 
 
  Details
6/3/2022 Mirati Therapeutics MRTX Maintain Buy
(Buy)
 
 
  Details
6/1/2022 Mirati Therapeutics MRTX Maintain Buy
(Buy)
 
 
  Details
5/27/2022 Mirati Therapeutics MRTX Maintain Buy
(Buy)
 
 
  Details
5/13/2022 Mirati Therapeutics MRTX Maintain Buy
(Buy)
 
 
  Details
5/13/2022 Kinnate Biopharma KNTE Maintain Buy
(Buy)
 
 
  Details
5/10/2022 Revolution RVMD Maintain Buy
(N/A)
 
 
  Details
5/5/2022 Mirati Therapeutics MRTX Maintain Buy
(Buy)
 
 
  Details
3/29/2022 Kinnate Biopharma KNTE Maintain Buy
(Buy)
 
 
  Details
3/15/2022 Ideaya Biosciences IDYA Maintain Buy
(Buy)
 
 
  Details
3/9/2022 Ideaya Biosciences IDYA Upgrade Buy
(Hold)
12.19
(45.88)
276.37% Details
3/1/2022 Mirati Therapeutics MRTX Maintain Buy
(Buy)
 
 
  Details
3/1/2022 Mirati Therapeutics MRTX Maintain Buy
(N/A)
 
 
  Details
3/1/2022 Revolution RVMD Upgrade Buy
(Hold)
18.92
(29.74)
57.19% Details
2/16/2022 Mirati Therapeutics MRTX Maintain Buy
(Buy)
 
 
  Details
2/11/2022 Kinnate Biopharma KNTE Maintain Buy
(Buy)
 
 
  Details
2/8/2022 Mirati Therapeutics MRTX Maintain Buy
(Buy)
 
 
  Details
1/7/2022 Kinnate Biopharma KNTE Maintain Buy
(N/A)
 
 
  Details
11/9/2021 Mirati Therapeutics MRTX Maintain Buy
(N/A)
 
 
  Details
9/23/2021 Ideaya Biosciences IDYA New Coverage Hold
(N/A)
27.02
(12.19)
-54.89% Details
9/23/2021 Revolution RVMD New Coverage Hold
(N/A)
32.05
(29.74)
-7.21% Details
9/23/2021 Repare Therapeutics RPTX New Coverage Buy
(N/A)
28.79
(26.21)
-8.96% Details
9/23/2021 Kinnate Biopharma KNTE New Coverage Buy
(N/A)
22.45
(2.51)
-88.82% Details
9/23/2021 Mirati Therapeutics MRTX New Coverage Buy
(N/A)
167.09
(58.70)
-64.87% Details
6/23/2020 CRISPR Therapeutics CRSP Maintain Hold
(N/A)
 
 
  Details
6/22/2020 CRISPR Therapeutics CRSP Maintain Hold
(N/A)
 
 
  Details
3/5/2020 CRISPR Therapeutics CRSP New Coverage Hold
(N/A)
51.15
(83.99)
64.2% Details